Oxygenta Pharmaceutical Ltd has notified the BSE of an upcoming board meeting scheduled for Saturday, May 23, 2026, at the company's corporate office. The intimation, dated May 19, 2026, was issued pursuant to Regulation 29 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Details

The following key matters are scheduled to be considered at the board meeting:

Agenda for the Meeting

The board will convene to deliberate on the following items:

• Audited Financial Results for the quarter and year ended March 31, 2026
• Audit Report for the year ended March 31, 2026
• Any other business with the permission of the Chair

The intimation was signed by Kumkum Bajaj, Company Secretary & Compliance Officer of Oxygenta Pharmaceutical Ltd, and submitted to the Manager, BSE Limited, P. J. Towers, Dalal Street, Mumbai-400001.

Oxygenta pharmaceutical has filed its quarterly compliance certificate for securities dematerialization with BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The certificate covers the quarter ended March 31, 2026, and was submitted on April 15, 2026.

Regulatory Compliance Details

The compliance certificate was filed under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This regulation mandates companies to provide details of securities dematerialized during each quarter to all stock exchanges where their shares are listed.

Company Secretary Certification

The certificate was signed by Kumkum Bajaj, Company Secretary and Compliance Officer (Membership No.: ACS76548), who digitally signed the document on April 15, 2026. The filing confirms that all required details of securities dematerialized during the quarter have been furnished to stock exchanges where the company's shares are listed.

RTA Verification

Venture Capital and Corporate Investments Private Limited, serving as the company's Registrar and Transfer Agent (RTA), provided verification through a letter dated April 3, 2026. The RTA confirmed compliance with dematerialization procedures and proper record maintenance.

Depository Operations

The RTA certified that securities received for dematerialization were properly processed according to regulatory requirements. The verification process included:

• Mutilation and cancellation of physical certificates after due verification
• Update of depository names in company records as registered owners
• Completion of processing within 15 days of receiving valid Dematerialization Request Form (DRF) and share certificates
• Furnishing details to relevant stock exchanges

Both National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) were updated as registered owners in the company's records, ensuring compliance with depository regulations.